{"id":47491,"date":"2022-08-19T18:02:50","date_gmt":"2022-08-19T16:02:50","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\/"},"modified":"2022-08-19T18:02:50","modified_gmt":"2022-08-19T16:02:50","slug":"l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\/","title":{"rendered":"L2P Research\u00ae Labs Continues unparalleled Growth as the Premier Minority-Owned Preclinical Research Lab in the U.S."},"content":{"rendered":"
\n

ANNVILLE, Pa.–(BUSINESS WIRE)–L2P Research Labs, a leading preclinical CRO, today announced its annual research accomplishments.\n<\/p>\n

<\/a><\/p>\n

\nDr. Suresh Anaganti, Chief Executive Officer of L2P Research Labs, shared contribution to preclinical data published in Cell Reports.\n<\/p>\n

\nLink: https:\/\/www.cell.com\/cell-reports\/pdf\/S2211-1247(21)01308-5.pdf<\/a>\n<\/p>\n

\nIn addition to prestigious Cell Reports, L2P also announces its contribution to research work published in Sciences advances.\n<\/p>\n

\nLink: https:\/\/www.science.org\/doi\/epdf\/10.1126\/sciadv.abi7511<\/a>\n<\/p>\n

\nAs a Contract Research Laboratory specialized in Immune oncology, we are happy to share that our Renal carcinoma tumor model has been used to study Alphataxin, a small molecule drug that elevates tumor infiltration of CD4+ T- cells.\n<\/p>\n

\nLink: https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.739080\/full<\/a>\n<\/p>\n

\nL2P Research Labs brings unique capabilities and solid reputation in providing Preclinical Research services. Recently, L2P added 5,000 SFT GLP-compliant testing facility in Long Island, focused on providing Bioanalytical services.\n<\/p>\n

\nAbout L2P Research Labs\n<\/p>\n

\nL2P Research is a Pennsylvania based Research organization that provides integrated R&D support in all the key areas of pharmaceutical development. With a large worldwide customer base, L2P provides a complete array of research services as required for Investigational New Drug Applications (IND).\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMs. Kerry Lucas, Administrative Manager
\n
L2P Research, LLC
\n
51 Oxford Road
\n
Annville, Pa 17003
\n
Kerry@l2presearch.com<\/a>
(844) 527-5227\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

ANNVILLE, Pa.–(BUSINESS WIRE)–L2P Research Labs, a leading preclinical CRO, today announced its annual research accomplishments. Dr. Suresh Anaganti, Chief Executive Officer of L2P Research Labs, shared contribution to preclinical data published in Cell Reports. Link: https:\/\/www.cell.com\/cell-reports\/pdf\/S2211-1247(21)01308-5.pdf In addition to prestigious Cell Reports, L2P also announces its contribution to research work published in Sciences advances. Link: … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47491","6":"format-standard","7":"category-industry"},"yoast_head":"\nL2P Research\u00ae Labs Continues unparalleled Growth as the Premier Minority-Owned Preclinical Research Lab in the U.S. - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L2P Research\u00ae Labs Continues unparalleled Growth as the Premier Minority-Owned Preclinical Research Lab in the U.S. - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"ANNVILLE, Pa.–(BUSINESS WIRE)–L2P Research Labs, a leading preclinical CRO, today announced its annual research accomplishments. Dr. Suresh Anaganti, Chief Executive Officer of L2P Research Labs, shared contribution to preclinical data published in Cell Reports. Link: https:\/\/www.cell.com\/cell-reports\/pdf\/S2211-1247(21)01308-5.pdf In addition to prestigious Cell Reports, L2P also announces its contribution to research work published in Sciences advances. Link: ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-19T16:02:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220819005274\/en\/1548899\/21\/LOGO_good.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"L2P Research\u00ae Labs Continues unparalleled Growth as the Premier Minority-Owned Preclinical Research Lab in the U.S.\",\"datePublished\":\"2022-08-19T16:02:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\\\/\"},\"wordCount\":244,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220819005274\\\/en\\\/1548899\\\/21\\\/LOGO_good.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\\\/\",\"name\":\"L2P Research\u00ae Labs Continues unparalleled Growth as the Premier Minority-Owned Preclinical Research Lab in the U.S. - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220819005274\\\/en\\\/1548899\\\/21\\\/LOGO_good.jpg\",\"datePublished\":\"2022-08-19T16:02:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220819005274\\\/en\\\/1548899\\\/21\\\/LOGO_good.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220819005274\\\/en\\\/1548899\\\/21\\\/LOGO_good.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"L2P Research\u00ae Labs Continues unparalleled Growth as the Premier Minority-Owned Preclinical Research Lab in the U.S.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L2P Research\u00ae Labs Continues unparalleled Growth as the Premier Minority-Owned Preclinical Research Lab in the U.S. - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\/","og_locale":"en_US","og_type":"article","og_title":"L2P Research\u00ae Labs Continues unparalleled Growth as the Premier Minority-Owned Preclinical Research Lab in the U.S. - Pharma Trend","og_description":"ANNVILLE, Pa.–(BUSINESS WIRE)–L2P Research Labs, a leading preclinical CRO, today announced its annual research accomplishments. Dr. Suresh Anaganti, Chief Executive Officer of L2P Research Labs, shared contribution to preclinical data published in Cell Reports. Link: https:\/\/www.cell.com\/cell-reports\/pdf\/S2211-1247(21)01308-5.pdf In addition to prestigious Cell Reports, L2P also announces its contribution to research work published in Sciences advances. Link: ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-19T16:02:50+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220819005274\/en\/1548899\/21\/LOGO_good.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"L2P Research\u00ae Labs Continues unparalleled Growth as the Premier Minority-Owned Preclinical Research Lab in the U.S.","datePublished":"2022-08-19T16:02:50+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\/"},"wordCount":244,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220819005274\/en\/1548899\/21\/LOGO_good.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\/","url":"https:\/\/pharma-trend.com\/en\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\/","name":"L2P Research\u00ae Labs Continues unparalleled Growth as the Premier Minority-Owned Preclinical Research Lab in the U.S. - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220819005274\/en\/1548899\/21\/LOGO_good.jpg","datePublished":"2022-08-19T16:02:50+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220819005274\/en\/1548899\/21\/LOGO_good.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220819005274\/en\/1548899\/21\/LOGO_good.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/l2p-research-labs-continues-unparalleled-growth-as-the-premier-minority-owned-preclinical-research-lab-in-the-u-s\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"L2P Research\u00ae Labs Continues unparalleled Growth as the Premier Minority-Owned Preclinical Research Lab in the U.S."}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47491","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47491"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47491\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47491"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47491"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47491"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}